Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 22, 2018 08:00 ET | Source: Chimerix, Inc.

Chimerix to Announce Fourth Quarter and Full Year 2017 Financial Results on March 1, 2018

DURHAM, N.C., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today...
January 05, 2018 07:00 ET | Source: Chimerix, Inc.

Chimerix Initiates AdAPT Study for Oral Brincidofovir and Advances IV Brincidofovir to Patient Studies

- Pivotal AdAPT Study of Oral Brincidofovir for Adenovirus Now Enrolling - - No GI Adverse Effects for IV Brincidofovir 10 mg - - Announces First Antiviral Specific for Norovirus Now In Clinical...
January 03, 2018 16:01 ET | Source: Chimerix, Inc.

Chimerix to Present at the 36th Annual J.P. Morgan Healthcare Conference

DURHAM, N.C., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to provide solutions to the growing population of immunocompromised...
November 08, 2017 07:00 ET | Source: Chimerix, Inc.

Chimerix Announces Third Quarter 2017 Financial Results

DURHAM, N.C., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today reported financial results and...
November 07, 2017 08:00 ET | Source: Chimerix, Inc.

Chimerix to Present at the Stifel 2017 Healthcare Conference

DURHAM, N.C., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that M. Michelle...
November 01, 2017 08:00 ET | Source: Chimerix, Inc.

Chimerix to Announce Third Quarter 2017 Financial Results on November 8, 2017

DURHAM, N.C., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company discovering, developing and commercializing medicines that improve outcomes for...
September 20, 2017 08:00 ET | Source: Chimerix, Inc.

Chimerix to Present at Cantor Fitzgerald Global Healthcare Conference

DURHAM, N.C., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that M. Michelle...
September 12, 2017 07:00 ET | Source: Chimerix, Inc.

Chimerix Appoints Heather Knight-Trent, PharmD, as Vice President of Regulatory Affairs

DURHAM, N.C., Sept. 12, 2017 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company committed to discovering, developing and commercializing medicines that improve outcomes for...
August 07, 2017 07:00 ET | Source: Chimerix, Inc.

Chimerix Announces Second Quarter 2017 Financial Results

DURHAM, N.C., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today reported financial results and...
July 31, 2017 08:30 ET | Source: Chimerix, Inc.

Chimerix to Announce Second Quarter 2017 Financial Results on August 7, 2017

DURHAM, N.C., July 31, 2017 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company discovering, developing and commercializing medicines that improve outcomes for...